Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AFA urges FDA to wait for McNeil raw data on aspirin/alcohol link at "feedback" meeting.

This article was originally published in The Tan Sheet

Executive Summary

AFA URGES FDA TO WAIT FOR McNEIL RAW DATA ON ASPIRIN/ALCOHOL INTERACTION before proposing an alcohol warning on aspirin products. At a July 11 "OTC feedback" meeting, Aspirin Foundation of America outside counsel Bruce Dickson (Washington, D.C. law firm Paul, Hastings, Janofsky & Walker) objected to FDA's plan to require an alcohol warnings on aspirin-containing OTC analgesics ("The Tan Sheet" Jan. 16, p. 3).
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084033

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel